• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Certara, Inc. - Common Stock (NQ:CERT)

6.970 +0.240 (+3.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Beyond The Numbers: 4 Analysts Discuss Certara Stock ↗
September 27, 2024
 
Via Benzinga
News headline image
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday ↗
September 27, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
September 27, 2024
 
Via Benzinga
News headline image
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024
The pre-competitive scientific research consortium of top pharmaceutical companies remains a critical force in advancing qualified PBPK modeling and simulation to further drug development and... 
From Certara
Via GlobeNewswire
News headline image
Decoding 4 Analyst Evaluations For Certara ↗
April 04, 2024
 
Via Benzinga
News headline image
Analyst Scoreboard: 4 Ratings For Certara ↗
March 01, 2024
 
Via Benzinga
News headline image
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024
Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to select a higher starting dose that would lower costs and reduce cycle times 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
August 21, 2024
From Certara
Via GlobeNewswire
News headline image
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
From Certara
Via GlobeNewswire
News headline image
Earnings Scheduled For February 29, 2024 ↗
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Recap: Certara Q3 Earnings ↗
November 08, 2023
 
Via Benzinga
News headline image
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024 ↗
August 06, 2024
CERT stock results show that Certara missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024
Reiterates Full Year 2024 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024
From Certara
Via GlobeNewswire
News headline image
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024
From Certara
Via GlobeNewswire
News headline image
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024
AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From Certara
Via GlobeNewswire
News headline image
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024
From Certara
Via GlobeNewswire
News headline image
CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024 ↗
May 07, 2024
CERT stock results show that Certara met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Certara Reports First Quarter 2024 Financial Results
May 07, 2024
Reiterates Full Year 2024 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
April 16, 2024
From Certara
Via GlobeNewswire
News headline image
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
April 09, 2024
From Certara
Via GlobeNewswire
News headline image
Certara Reports Fourth Quarter 2023 Financial Results
February 29, 2024
Provides Full Year 2024 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
February 01, 2024
From Certara
Via GlobeNewswire
News headline image
Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies ↗
January 30, 2024
New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop could impact ETFs. 
Via Benzinga
News headline image
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
December 13, 2023
Combined organization establishes the life sciences industry’s largest quantitative systems pharmacology (QSP) center of excellence contributing to faster and more effective medicine development. 
From Certara
Via GlobeNewswire
News headline image
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
November 21, 2023
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies 
From Certara
Via GlobeNewswire
News headline image
Certara Reports Third Quarter 2023 Financial Results
November 08, 2023
Reiterates Full Year 2023 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
October 11, 2023
From Certara
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap